Nomura Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,300
Closed -$37.4K 1551
2022
Q1
$37.4K Hold
2,300
﹤0.01% 1188
2021
Q4
$109K Hold
2,300
﹤0.01% 971
2021
Q3
$167K Buy
+2,300
New +$166K ﹤0.01% 924

Other funds holding NBP

Nomura Asset Management's NBP Position: Q2 2022 in Review

Nomura Asset Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 2,300 shares — an estimated $37.4K sold.

Nomura Asset Management first reported a position in NBP in Q3 2021 and held it in 3 quarters. The position peaked at $167K in Q3 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

  • Nomura Asset Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Nomura Asset Management sold 2,300 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $37.4K.
  • Nomura Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2021 and held it in 3 quarters.
  • Nomura Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $167K in Q3 2021.
  • 97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on Nomura Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.